These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 21082509

  • 21. A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL.
    Deng L, Li XL, Ye DS, Blockeel C, Zhou XY, Chen SL, Chen X.
    Curr Med Sci; 2019 Apr; 39(2):278-284. PubMed ID: 31016522
    [Abstract] [Full Text] [Related]

  • 22. Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin.
    Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C.
    Fertil Steril; 2011 Jun 30; 95(8):2715-7. PubMed ID: 21550042
    [Abstract] [Full Text] [Related]

  • 23. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
    Martínez F, Rodríguez DB, Buxaderas R, Tur R, Mancini F, Coroleu B.
    Fertil Steril; 2011 Jun 30; 95(7):2432.e17-9. PubMed ID: 21513932
    [Abstract] [Full Text] [Related]

  • 24. GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome.
    Christopoulos G, Vlismas A, Carby A, Lavery S, Trew G.
    Hum Fertil (Camb); 2016 Sep 30; 19(3):199-206. PubMed ID: 27662416
    [Abstract] [Full Text] [Related]

  • 25. Withholding gonadotropins until human chorionic gonadotropin administration.
    Abdallah R, Kligman I, Davis O, Rosenwaks Z.
    Semin Reprod Med; 2010 Nov 30; 28(6):486-92. PubMed ID: 21082507
    [Abstract] [Full Text] [Related]

  • 26. GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at 'freeze-all strategy'.
    Ling LP, Phoon JW, Lau MS, Chan JK, Viardot-Foucault V, Tan TY, Nadarajah S, Tan HH.
    Reprod Biomed Online; 2014 Sep 30; 29(3):392-4. PubMed ID: 25042608
    [Abstract] [Full Text] [Related]

  • 27. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM, Gao HJ, He RH, Huang HF.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov 30; 41(11):740-4. PubMed ID: 17327030
    [Abstract] [Full Text] [Related]

  • 28. Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support.
    Engmann L, Benadiva C.
    Fertil Steril; 2012 Mar 30; 97(3):531-3. PubMed ID: 22245529
    [Abstract] [Full Text] [Related]

  • 29. Preventing ovarian hyperstimulation syndrome: guidance for the clinician.
    Humaidan P, Quartarolo J, Papanikolaou EG.
    Fertil Steril; 2010 Jul 30; 94(2):389-400. PubMed ID: 20416867
    [Abstract] [Full Text] [Related]

  • 30. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C.
    Fertil Steril; 2010 Feb 30; 93(3):847-54. PubMed ID: 19200959
    [Abstract] [Full Text] [Related]

  • 31. Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study.
    Bodri D, Guillén JJ, Trullenque M, Schwenn K, Esteve C, Coll O.
    Fertil Steril; 2010 May 01; 93(7):2418-20. PubMed ID: 19800620
    [Abstract] [Full Text] [Related]

  • 32. GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.
    O'Neill KE, Senapati S, Maina I, Gracia C, Dokras A.
    J Assist Reprod Genet; 2016 Sep 01; 33(9):1175-84. PubMed ID: 27349252
    [Abstract] [Full Text] [Related]

  • 33. Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support.
    Imbar T, Kol S, Lossos F, Bdolah Y, Hurwitz A, Haimov-Kochman R.
    Hum Reprod; 2012 Mar 01; 27(3):753-9. PubMed ID: 22252086
    [Abstract] [Full Text] [Related]

  • 34. Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol.
    Chen SL, Ye DS, Chen X, Yang XH, Zheng HY, Tang Y, He YX, Guo W.
    Hum Reprod; 2012 May 01; 27(5):1351-6. PubMed ID: 22419746
    [Abstract] [Full Text] [Related]

  • 35. Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization.
    Budinetz TH, Mann JS, Griffin DW, Benadiva CA, Nulsen JC, Engmann LL.
    Fertil Steril; 2014 Sep 01; 102(3):753-8. PubMed ID: 24954776
    [Abstract] [Full Text] [Related]

  • 36. Retrospective comparison of GnRH agonist trigger with HCG trigger in GnRH antagonist cycles in anticipated high-responders.
    Datta AK, Eapen A, Birch H, Kurinchi-Selvan A, Lockwood G.
    Reprod Biomed Online; 2014 Nov 01; 29(5):552-8. PubMed ID: 25246126
    [Abstract] [Full Text] [Related]

  • 37. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.
    Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM.
    Reprod Biomed Online; 2012 Feb 01; 24(2):134-41. PubMed ID: 22197130
    [Abstract] [Full Text] [Related]

  • 38. Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome.
    Kasum M, Orešković S, Franulić D, Čehić E, Lila A, Vujić G, Grgić F.
    Acta Clin Croat; 2017 Mar 01; 56(1):133-142. PubMed ID: 29120551
    [Abstract] [Full Text] [Related]

  • 39. Basic understanding of gonadotropin-releasing hormone-agonist triggering.
    Casper RF.
    Fertil Steril; 2015 Apr 01; 103(4):867-9. PubMed ID: 25712575
    [Abstract] [Full Text] [Related]

  • 40. Gonadotropin-releasing hormone agonist ovulation trigger-beyond OHSS prevention.
    Castillo JC, Haahr T, Martínez-Moya M, Humaidan P.
    Ups J Med Sci; 2020 May 01; 125(2):138-143. PubMed ID: 32208810
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.